Chemical inhibitors of 1200011I18Rik can exert their effects through various mechanisms by targeting specific signaling pathways and enzymes that are involved in the regulation and activity of this protein. Staurosporine, for example, is a potent inhibitor of protein kinases, which can prevent the phosphorylation of 1200011I18Rik, leading to its functional inhibition. This lack of phosphorylation prevents the activation of 1200011I18Rik or its ability to phosphorylate other substrates. Similarly, Bisindolylmaleimide I specifically targets Protein Kinase C, which, by inhibiting this kinase, reduces the phosphorylation and subsequent activation of 1200011I18Rik, leading to its inhibition. LY294002 and Wortmannin are both inhibitors of PI3K and by inhibiting this kinase, they can prevent the activation of the PI3K/Akt pathway, a crucial signaling route that may control the activity of 1200011I18Rik. Rapamycin inhibits mTOR, another key protein in cellular signaling, which can lead to the inhibition of 1200011I18Rik if it is regulated by mTOR-dependent pathways.
Further, PD98059 and U0126 are inhibitors of MEK, which is part of the MAPK/ERK pathway. By preventing the activation of this pathway, they can reduce the activity of 1200011I18Rik if it lies downstream. SB203580 acts on p38 MAPK, inhibiting the stress response pathway, which in turn could lead to the inhibition of 1200011I18Rik. SP600125 targets JNK, inhibiting this kinase and potentially leading to the inhibition of 1200011I18Rik if it is a downstream effector. Dasatinib and PP2 focus on Src family kinases, which when inhibited, can prevent the activation or function of 1200011I18Rik if it interacts with Src signaling. Lastly, Lapatinib inhibits EGFR/HER2 tyrosine kinases, which can lead to the inhibition of 1200011I18Rik by blocking the signaling pathways that may regulate or be regulated by this protein. Each of these chemicals acts to inhibit specific kinases or pathways, which in turn leads to the inhibition of 1200011I18Rik by preventing its activation, regulation, or interaction with other cellular components.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Inhibits protein kinases that could phosphorylate 1200011I18Rik, thereby inhibiting its activation or its ability to phosphorylate other proteins. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Targets Protein Kinase C which might be involved in the regulation or activation of 1200011I18Rik, inhibiting its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor which would inhibit the PI3K/Akt pathway, potentially reducing the activity of 1200011I18Rik if it is downstream of PI3K signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor that would inhibit the PI3K/Akt pathway, potentially reducing the activity of 1200011I18Rik if it is downstream of PI3K. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which could be involved in the regulation or downstream signaling affecting 1200011I18Rik activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor which would inhibit the MAPK/ERK pathway, potentially reducing the activity of 1200011I18Rik if it is downstream of MAPK/ERK signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Another MEK inhibitor which would inhibit the MAPK/ERK pathway, potentially reducing the activity of 1200011I18Rik downstream of MAPK/ERK. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor which would inhibit the p38 MAPK stress response pathway, potentially inhibiting 1200011I18Rik activity if it is a downstream target. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor which would inhibit the JNK signaling pathway, potentially inhibiting 1200011I18Rik activity if it is a downstream target. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Inhibits Src family kinases which could be involved in the regulation or activation of 1200011I18Rik, inhibiting its function. | ||||||